1 |
Mathiew M, Dennis BM, Bennetts F, Su NNE, Nguyen N, Botteon A, Baell JB, Ventura S. Synthesis of 2-phenyl-5,6,7,8-tetrahydroquinoxaline derivatives and screening for P2X1-purinoceptor antagonist activity in isolated preparations of rat vas deferens, for translation into a male contraceptive. Biol Reprod. 2020;103:323-332.
DOI
|
2 |
Goetz AS, King HK, Ward SD, True TA, Rimele TJ, Saussy DL Jr. BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors. Eur J Pharmacol. 1995;272:R5-R6.
|
3 |
White CW, Choong YT, Short JL, Exintaris B, Malone DT, Allen AM, Evans RJ, Ventura S. Male contraception via simultaneous knockout of α1A-adrenoceptors and P2X1-purinoceptors in mice. Proc Natl Acad Sci U S A. 2013;110:20825-20830.
DOI
|
4 |
Paz GF, Shilon M, Homonnai ZT. The possible use of phenoxybenzamine as a male contraceptive drug: studies on male rats. Contraception. 1984;29:189-195.
DOI
|
5 |
Marshall I, Burt RP, Green GM, Hussain MB, Chapple CR. Different subtypes of α1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053. Br J Pharmacol. 1996;119:407-415.
DOI
|
6 |
Kenny BA, Miller AM, Williamson IJ, O'Connell J, Chalmers DH, Naylor AM. Evaluation of the pharmacological selectivity profile of α1 adrenoceptor antagonists at prostatic α1 adrenoceptors: binding, functional and in vivo studies. Br J Pharmacol. 1996;118:871-878.
DOI
|
7 |
Williams TJ, Blue DR, Daniels DV, Davis B, Elworthy T, Gever JR, Kava MS, Morgans D, Padilla F, Tassa S, Vimont RL, Chapple CR, Chess-Williams R, Eglen RM, Clarke DE, Ford AP. In vitro α1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel α1A-adrenoceptor selective antagonists. Br J Pharmacol. 1999;127:252-258.
DOI
|
8 |
Docherty JR. The pharmacology of α1-adrenoceptor subtypes. Eur J Pharmacol. 2019;855:305-320.
DOI
|
9 |
Alsufyani HA, Docherty JR. Involvement of G proteins and Rho kinase in α1-adrenoceptor mediated contractions of the rat portal vein. Can J Physiol Pharmacol. 2021;99:654-659.
DOI
|
10 |
Perez DM, Piascik MT, Graham RM. Solution-phase library screening for the identification of rare clones: isolation of an α1D-adrenergic receptor cDNA. Mol Pharmacol. 1991;40:876-883.
|
11 |
Seto SW, Bexis S, McCormick PA, Docherty JR. Actions of thalidomide in producing vascular relaxations. Eur J Pharmacol. 2010;644:113-119.
DOI
|
12 |
Bultmann R, Trendelenburg M, Tuluc F, Wittenburg H, Starke K. Concomitant blockade of P2X-receptors and ecto-nucleotidases by P2-receptor antagonists: functional consequences in rat vas deferens. Naunyn Schmiedebergs Arch Pharmacol. 1999;359:339-344.
DOI
|
13 |
Mulryan K, Gitterman DP, Lewis CJ, Vial C, Leckie BJ, Cobb AL, Brown JE, Conley EC, Buell G, Pritchard CA, Evans RJ. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature. 2000;403:86-89.
DOI
|
14 |
Cleary L, Vandeputte C, Docherty JR. Investigation of neurotransmission in vas deferens from α2A/D-adrenoceptor knockout mice. Br J Pharmacol. 2002;136:857-864.
DOI
|
15 |
Alsufyani HA, McCormick PA, Docherty JR. Both α1B- and α1A-adrenoceptor subtypes are involved in contractions of rat spleen. Pharmacol Rep. 2021;73:255-260.
DOI
|
16 |
Cleary L, Slattery J, Bexis S, Docherty JR. Sympathectomy reveals α1A- and α1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens. Br J Pharmacol. 2004;143:745-752.
DOI
|
17 |
Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD, Clarke DE. Pharmacological pleiotropism of the human recombinant α1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol. 1997;121:1127-1135.
DOI
|
18 |
Chiba Y, Misawa M. The role of RhoA-mediated Ca2+ sensitization of bronchial smooth muscle contraction in airway hyperresponsiveness. J Smooth Muscle Res. 2004;40:155-167.
DOI
|
19 |
Yono M, Tanaka T, Tsuji S, Hori M, Irie S, Sakata Y, Otani M, Yoshida M, Latifpour J. A comparison of the expression and contractile function of α1-adrenoceptors in seminal vesicle and vas deferens from normotensive and hypertensive rats. Eur J Pharmacol. 2012;694:104-110.
DOI
|
20 |
Young JS, Brain KL, Cunnane TC. Electrical and optical study of nerve impulse-evoked ATP-induced, P2X-receptor-mediated sympathetic neurotransmission at single smooth muscle cells in mouse isolated vas deferens. Neuroscience. 2007;148:82-91.
DOI
|
21 |
Bexis S, Cleary L, McGrath JC, Tanoue A, Tsujimoto G, Docherty JR. Alpha1D-adrenoceptors mediate nerve and agonist-evoked contractions in mouse vas deferens: evidence obtained from knockout technology. Auton Autacoid Pharmacol. 2008;28:81-85.
DOI
|
22 |
Docherty JR. Prazosin has low potency at α1A-adrenoceptors and high potency at α1D-adrenoceptors in rat vas deferens. Auton Autacoid Pharmacol. 2013;33:49-57.
DOI
|
23 |
Kjaergaard N, Kjaergaard B, Lauritsen JG. Prazosin, an adrenergic blocking agent inadequate as male contraceptive pill. Contraception. 1988;37:621-629.
DOI
|
24 |
Sanbe A, Tanaka Y, Fujiwara Y, Tsumura H, Yamauchi J, Cotecchia S, Koike K, Tsujimoto G, Tanoue A. Alpha1-adrenoceptors are required for normal male sexual function. Br J Pharmacol. 2007;152:332-340.
DOI
|
25 |
Homonnai ZT, Shilon M, Paz GF. Phenoxybenzamine--an effective male contraceptive pill. Contraception. 1984;29:479-491.
DOI
|
26 |
Ratnasooriya WD, Wadsworth RM. Impairment of fertility of male rats with prazosin. Contraception. 1990;41:441-447.
DOI
|
27 |
Gorodeski GI. Purinergic signalling in the reproductive system. Auton Neurosci. 2015;191:82-101.
DOI
|